cdmo.directory
← Compare landing

Boston Institute of Biotechnology, LLC vs CuriRx, Inc.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bostonbib/curirx

CategoryBoston Institute of Biotechnology, LLCCuriRx, Inc.
Listed sitecdmoboth
SummaryFull-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L.CuriRx provides formulation development, advanced bioprocessing, and analytical services to pharmaceutical companies. Capabilities include prefilled syringes, lyophilization, cell line development, upstream/downstream process development, and CMC analytical support via the CuriLytics® platform.
Services
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Upstream Processing
  • Downstream Processing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Microbial Fermentation
  • Vaccine Manufacturing
  • AAV Manufacturing
  • Viral Vector Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • Prefilled Syringe (PFS) Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Formulation Development
  • Prefilled Syringe (PFS) Filling
  • Lyophilization (Freeze Drying)
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Analytical Method Development & Validation
  • Stability Testing & Storage
  • Quality Control Testing
  • CMC Regulatory Submission Support
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Vaccine
  • AAV / Viral Vector Platform
  • Biologics (Other)
  • Small Molecule
  • Gene Therapy
IndicationsData not yet provided.Data not yet provided.
Locations
  • Southborough, Southborough, Massachusetts, United States
  • Zhangjiang (P01), Shanghai, Shanghai, China
  • Lingang (IP02), Shanghai, Shanghai, China
  • Lingang (IP03), Shanghai, Shanghai, China
  • Headquarters, Southborough, Massachusetts, United States
  • Headquarters, Wilmington, MA, USA
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.